Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis (NCT00748254)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this feasibility study is to determine if a new emerging technology called photoacoustic tomography (PAT) can be adapted for use in humans for the detection of chronic rheumatoid arthritis.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (3 items) and avoid the listed exclusions (8 items).
Location: Universtity of Michigan Health System — Ann Arbor, Michigan
Age range: 18 Years
🧪 Interventions in This Study
- Laser Based Photoacoustic Tomography, MRI, Ultrasound (PROCEDURE)
- laser based photoacoustic tomography, MRI, ultrasound (PROCEDURE)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator.
- Pregnant patients.
- Patients who is claustrophobic.
- Patients with impaired renal function cannot participate in this study such as elevate creatinine clearance, patients on kidney dialysis etc.
- Patients with shock hypotension or unstable low blood pressure.
- Patients with Rhabdomyolysis.
- Patients who have had a contrast enhanced (with gadolinium) MRA (magnetic resonance angiography)/ or MRI within the last 3 months. (Contrast is a medication injected into a vein during a imaging examination that helps produce clearer images/pictures).
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- Universtity of Michigan Health System — Ann Arbor, Michigan
📞 Contact the Study Coordinator
Phone: (734) 615-1646
Email: safam@med.umich.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Arthritis, Rheumatoid
- Chronic Pain in Rheumatoid Arthritis — Denver, Colorado
- Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis — Boston, Massachusetts
- A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014) — Glendale, Arizona
- R-2487 in Patients With Rheumatoid Arthritis — San Diego, California
- INFINITY™ With ADAPTIS™ Technology Study — Gilbert, Arizona
Explore by condition: All Arthritis, Rheumatoid clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.